Quick Contact
Professor Ian Frazer AC is a world-leading immunologist and medical researcher, best known for developing the human papillomavirus (HPV) cervical cancer vaccines, which have been administered in over 90 countries to more than 40 million women and girls. He is now pioneering research toward the world’s first vaccine for skin cancer.
Professor Frazer has received numerous national and international accolades, including Australian of the Year (2006), the Prime Minister’s Science Prize (2008), the Balzan Prize (2008), the Howard Florey Medal (2007), and the CSIRO Eureka Prize for Leadership in Science (2005). He is a Fellow of the Australian Academy of Science.
He is Director of the Diamantina Institute for Cancer, Immunology and Metabolic Medicine at the University of Queensland, heads the Centre for Immunology and Cancer Research, and chairs the medical and scientific advisory committee of the Queensland Cancer Fund. Professor Frazer also advises the World Health Organization and the Bill & Melinda Gates Foundation on HPV vaccines and teaches immunology to undergraduate and graduate students.
His research focuses on immunoregulation and the development of immunotherapeutic vaccines for virus-associated cancers. Professor Frazer also directs the biotechnology start-up Coridon, focused on optimising polynucleotide vaccine protein expression.
Trained as a renal physician and clinical immunologist in Edinburgh, Scotland, Professor Frazer emigrated to Australia in 1980 and has spent decades advancing viral immunology and preventive medicine, inspiring students, researchers, and audiences worldwide.
